Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial-Reference-Cited by-同舟云学术

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

Published:2023-03 Issue:3 Volume:29 Page:208.e1-208.e6
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Shaw Bronwen E.,Jimenez-Jimenez Antonio Martin,Burns Linda J.^ORCID,Logan Brent R.,Khimani Farhad,Shaffer Brian C.,Shah Nirav N.,Mussetter Alisha,Tang Xiao-Ying^ORCID,McCarty John M.,Alavi Asif,Farhadfar Nosha,Jamieson Katarzyna,Hardy Nancy M.,Choe Hannah,Ambinder Richard F.,Anasetti Claudio,Perales Miguel-Angel^ORCID,Spellman Stephen R.,Howard Alan,Komanduri Krishna V.,Luznik Leo,Norkin Maxim,Pidala Joseph A.,Ratanatharathorn Voravit,Confer Dennis L.,Devine Steven M.^ORCID,Horowitz Mary M.^ORCID,Bolaños-Meade Javier

Funder

Health Resources and Services Administration

Office of Naval Research

National Heart Lung and Blood Institute

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference15 articles.

1. Auletta JJ, Kou J, Chen M, Shaw BE. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides. 2021. Available at:https://www.cibmtr.org/ReferenceCenter/SlidesReports/Summary Slides/Pages/index.aspx. Accessed October 16, 2023.

2. Prospective evaluation of unrelated donor cord blood and haploidentical donor access reveals graft availability varies by patient ancestry: practical implications for donor selection;Kosuri;Biol Blood Marrow Transplant.,2017

3. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation;Ciurea;Transplantation,2009

5. National Marrow Donor Program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide;Shaw;J Clin Oncol,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations;Transplantation and Cellular Therapy;2024-09

3. From clones to immunopeptidomes: New developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-09

4. Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies;Journal of Clinical Oncology;2024-08-21

5. Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors;Journal of Clinical Oncology;2024-07-17